比較婦女應力性尿失禁使用不同路徑吊帶手術之長期手術效果

吳怡萱1、江元宏2、陳聖復2、郭漢崇2

1高雄市立小港醫院 泌尿科; 2花蓮慈濟醫院 泌尿部

Surgical Outcomes of Different Suburethral Sling Procedures for Female Stress Urinary Incontinence

Yi-Hsuan Wu1, Yuan-Hong Jiang2, Sheng-Fu Chen2, Hann-Chorng Kuo2

1Department of Urology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;

2Department of Urology, Buddhist Tzu Chi General Hospital, Tzu Chi University, Hualien, Taiwan

 

Abstract

Purpose: Stress urinary incontinence (SUI) annoyed women worldwide and surgery remain importance for those who failed to observative managements.

Methods: We retrospectively reviewed medical records of 533 female patients with mixed urinary incontinence and predominant SUI in a medical center. Patients were divided into four groups: pubovaginal sling (PVS) alone, transobturator suburethral sling (TOT) alone, PVS with colporrhaphy, and TOT with colporrhaphy. The primary outcome was the long-term cumulative success rate in different groups and a successful outcome defined as dry or less than one pad usage per day. The secondary outcomes were subjective postoperative lower urinary tract symptoms and various perioperative complications.

Results: The long-term cumulative success rate of PVS group with or without colporrhaphy are significantly higher than those in TOT group with or without colporrhaphy (p< 0.001). The group of PVS with concurrent colporrhaphy obtained highest success rate, followed by the PVS alone, TOT with colporrhaphy and TOT alone (p=0.003). Furthermore, highest rate of persistent overactive bladder was noted in TOT alone group (p< 0.001).  

Conclusion: This study suggest PVS is superior to TOT in terms of incontinent symptom control and long-term success rate. Concurrent colporrhaphy may be also helpful for anti-incontinent effect.

 

    位置
    資料夾名稱
    摘要
    上傳者
    TUA線上教育_家琳
    單位
    台灣泌尿科醫學會
    建立
    2024-06-11 19:06:58
    最近修訂
    2024-06-11 19:07:20
    1. 1.
      Podium 01
    2. 2.
      Podium 02
    3. 3.
      Podium 03
    4. 4.
      Podium 04
    5. 5.
      Podium 05
    6. 6.
      Podium 06
    7. 7.
      Podium 07
    8. 8.
      Moderated Poster 01
    9. 9.
      Moderated Poster 02
    10. 10.
      Moderated Poster 03
    11. 11.
      Moderated Poster 04
    12. 12.
      Moderated Poster 05
    13. 13.
      Non-Discussion Poster